shopno
Sep 25, 10:02 AM
$NGEN Good timeline breakdown. One caveat though is: it’s already 4+ months since single-day ~50% stock price collapse and price not yet recovered— EXACTLY as I had been predicting.
So your 0-6 months from now to recover price say to
$3 is quite low ROI from the point of collapse, as it’s only
$2 to
$3 in ~a year.
IMO, some FDA recognition can push the price to 2x, along with trial update on other indications. That being said I am not very optimistic on this incompetent management from untimely dilutions to lack of communication, like i wont surprise if NGEN didn’t file a BTD yet.
Also, I don’t agree that this incompetent management can enroll all 150 patients by Q3 2027. None in the management team have prior top caliber execution profile (I am well aware Adam got big stake, and he must look to make
$B+). I will wait to get back in NGEN after seeing P3 progress — maybe later this year or in Q1 2027.
0 replies
